Cargando…
Absence of p21 expression is associated with abnormal p53 in human breast carcinomas.
The p53 tumour-suppressor gene is important in the regulation of cell growth and apoptosis, and loss of functional wild-type activity may be associated with tumour formation and resistance to therapy. Differentiation of functionally normal wild-type protein from mutant or abnormal protein remains di...
Autores principales: | Ellis, P. A., Lonning, P. E., Borresen-Dale, A., Aas, T., Geisler, S., Akslen, L. A., Salter, I., Smith, I. E., Dowsett, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2227991/ https://www.ncbi.nlm.nih.gov/pubmed/9275025 |
Ejemplares similares
-
Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer
por: Akslen, L A, et al.
Publicado: (2011) -
p16(INK4A) as a predictive factor in patients with locally advanced breast cancer treated with neoadjuvant doxorubicin monotherapy
por: Geisler, S, et al.
Publicado: (2000) -
Expression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters
por: Baumbusch, Lars O, et al.
Publicado: (2006) -
Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.
por: Helland, A., et al.
Publicado: (1998) -
Expression of wild-type and mutated TP53 in breast carcinomas
por: Baumbusch, LO, et al.
Publicado: (2005)